Overactive Bladder Treatment Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: O7C6D5FA833BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Overactive Bladder Treatment in Global, including the following market information:

Global Overactive Bladder Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Overactive Bladder Treatment market was valued at 5591.3 million in 2020 and is projected to reach US$ 6261.6 million by 2027, at a CAGR of 2.9% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Overactive Bladder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Overactive Bladder Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Overactive Bladder Treatment Market Segment Percentages, By Type, 2020 (%)

• Drugs
• Device

China Overactive Bladder Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Overactive Bladder Treatment Market Segment Percentages, By Application, 2020 (%)

• Idiopathic Overactive Bladder
• Neurogenic Overactive Bladder

Global Overactive Bladder Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Overactive Bladder Treatment Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Overactive Bladder Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Overactive Bladder Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Allergan
• Astellas Pharma
• Pfizer
• Johnson & Johnson
• Medtronic
• KYORIN Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Overactive Bladder Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Overactive Bladder Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OVERACTIVE BLADDER TREATMENT OVERALL MARKET SIZE

2.1 Global Overactive Bladder Treatment Market Size: 2021 VS 2027
2.2 Global Overactive Bladder Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Overactive Bladder Treatment Players in Global Market
3.2 Top Global Overactive Bladder Treatment Companies Ranked by Revenue
3.3 Global Overactive Bladder Treatment Revenue by Companies
3.4 Top 3 and Top 5 Overactive Bladder Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Overactive Bladder Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Overactive Bladder Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Overactive Bladder Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Overactive Bladder Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Overactive Bladder Treatment Market Size Markets, 2021 & 2027
  4.1.2 Drugs
  4.1.3 Device
4.2 By Type - Global Overactive Bladder Treatment Revenue & Forecasts
  4.2.1 By Type - Global Overactive Bladder Treatment Revenue, 2016-2021
  4.2.2 By Type - Global Overactive Bladder Treatment Revenue, 2022-2027
  4.2.3 By Type - Global Overactive Bladder Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Overactive Bladder Treatment Market Size, 2021 & 2027
  5.1.2 Idiopathic Overactive Bladder
  5.1.3 Neurogenic Overactive Bladder
5.2 By Application - Global Overactive Bladder Treatment Revenue & Forecasts
  5.2.1 By Application - Global Overactive Bladder Treatment Revenue, 2016-2021
  5.2.2 By Application - Global Overactive Bladder Treatment Revenue, 2022-2027
  5.2.3 By Application - Global Overactive Bladder Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Overactive Bladder Treatment Market Size, 2021 & 2027
6.2 By Region - Global Overactive Bladder Treatment Revenue & Forecasts
  6.2.1 By Region - Global Overactive Bladder Treatment Revenue, 2016-2021
  6.2.2 By Region - Global Overactive Bladder Treatment Revenue, 2022-2027
  6.2.3 By Region - Global Overactive Bladder Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Overactive Bladder Treatment Revenue, 2016-2027
  6.3.2 US Overactive Bladder Treatment Market Size, 2016-2027
  6.3.3 Canada Overactive Bladder Treatment Market Size, 2016-2027
  6.3.4 Mexico Overactive Bladder Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Overactive Bladder Treatment Revenue, 2016-2027
  6.4.2 Germany Overactive Bladder Treatment Market Size, 2016-2027
  6.4.3 France Overactive Bladder Treatment Market Size, 2016-2027
  6.4.4 U.K. Overactive Bladder Treatment Market Size, 2016-2027
  6.4.5 Italy Overactive Bladder Treatment Market Size, 2016-2027
  6.4.6 Russia Overactive Bladder Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries Overactive Bladder Treatment Market Size, 2016-2027
  6.4.8 Benelux Overactive Bladder Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Overactive Bladder Treatment Revenue, 2016-2027
  6.5.2 China Overactive Bladder Treatment Market Size, 2016-2027
  6.5.3 Japan Overactive Bladder Treatment Market Size, 2016-2027
  6.5.4 South Korea Overactive Bladder Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia Overactive Bladder Treatment Market Size, 2016-2027
  6.5.6 India Overactive Bladder Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Overactive Bladder Treatment Revenue, 2016-2027
  6.6.2 Brazil Overactive Bladder Treatment Market Size, 2016-2027
  6.6.3 Argentina Overactive Bladder Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Overactive Bladder Treatment Revenue, 2016-2027
  6.7.2 Turkey Overactive Bladder Treatment Market Size, 2016-2027
  6.7.3 Israel Overactive Bladder Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia Overactive Bladder Treatment Market Size, 2016-2027
  6.7.5 UAE Overactive Bladder Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Allergan
  7.1.1 Allergan Corporate Summary
  7.1.2 Allergan Business Overview
  7.1.3 Allergan Overactive Bladder Treatment Major Product Offerings
  7.1.4 Allergan Overactive Bladder Treatment Revenue in Global (2016-2021)
  7.1.5 Allergan Key News
7.2 Astellas Pharma
  7.2.1 Astellas Pharma Corporate Summary
  7.2.2 Astellas Pharma Business Overview
  7.2.3 Astellas Pharma Overactive Bladder Treatment Major Product Offerings
  7.2.4 Astellas Pharma Overactive Bladder Treatment Revenue in Global (2016-2021)
  7.2.5 Astellas Pharma Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Overactive Bladder Treatment Major Product Offerings
  7.3.4 Pfizer Overactive Bladder Treatment Revenue in Global (2016-2021)
  7.3.5 Pfizer Key News
7.4 Johnson & Johnson
  7.4.1 Johnson & Johnson Corporate Summary
  7.4.2 Johnson & Johnson Business Overview
  7.4.3 Johnson & Johnson Overactive Bladder Treatment Major Product Offerings
  7.4.4 Johnson & Johnson Overactive Bladder Treatment Revenue in Global (2016-2021)
  7.4.5 Johnson & Johnson Key News
7.5 Medtronic
  7.5.1 Medtronic Corporate Summary
  7.5.2 Medtronic Business Overview
  7.5.3 Medtronic Overactive Bladder Treatment Major Product Offerings
  7.5.4 Medtronic Overactive Bladder Treatment Revenue in Global (2016-2021)
  7.5.5 Medtronic Key News
7.6 KYORIN Pharmaceutical
  7.6.1 KYORIN Pharmaceutical Corporate Summary
  7.6.2 KYORIN Pharmaceutical Business Overview
  7.6.3 KYORIN Pharmaceutical Overactive Bladder Treatment Major Product Offerings
  7.6.4 KYORIN Pharmaceutical Overactive Bladder Treatment Revenue in Global (2016-2021)
  7.6.5 KYORIN Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Overactive Bladder Treatment Market Opportunities & Trends in Global Market
Table 2. Overactive Bladder Treatment Market Drivers in Global Market
Table 3. Overactive Bladder Treatment Market Restraints in Global Market
Table 4. Key Players of Overactive Bladder Treatment in Global Market
Table 5. Top Overactive Bladder Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Overactive Bladder Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Overactive Bladder Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Overactive Bladder Treatment Product Type
Table 9. List of Global Tier 1 Overactive Bladder Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Overactive Bladder Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Overactive Bladder Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Overactive Bladder Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Overactive Bladder Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Overactive Bladder Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Overactive Bladder Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Overactive Bladder Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Overactive Bladder Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Overactive Bladder Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Overactive Bladder Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Overactive Bladder Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Overactive Bladder Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Overactive Bladder Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Overactive Bladder Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Overactive Bladder Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Allergan Corporate Summary
Table 31. Allergan Overactive Bladder Treatment Product Offerings
Table 32. Allergan Overactive Bladder Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Overactive Bladder Treatment Product Offerings
Table 35. Astellas Pharma Overactive Bladder Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Overactive Bladder Treatment Product Offerings
Table 38. Pfizer Overactive Bladder Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Overactive Bladder Treatment Product Offerings
Table 41. Johnson & Johnson Overactive Bladder Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Medtronic Corporate Summary
Table 43. Medtronic Overactive Bladder Treatment Product Offerings
Table 44. Medtronic Overactive Bladder Treatment Revenue (US$, Mn), (2016-2021)
Table 45. KYORIN Pharmaceutical Corporate Summary
Table 46. KYORIN Pharmaceutical Overactive Bladder Treatment Product Offerings
Table 47. KYORIN Pharmaceutical Overactive Bladder Treatment Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Overactive Bladder Treatment Segment by Type
Figure 2. Overactive Bladder Treatment Segment by Application
Figure 3. Global Overactive Bladder Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Overactive Bladder Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Overactive Bladder Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Overactive Bladder Treatment Revenue in 2020
Figure 8. By Type - Global Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 12. US Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 24. China Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Overactive Bladder Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Overactive Bladder Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Allergan Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Astellas Pharma Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Pfizer Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Johnson & Johnson Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Medtronic Overactive Bladder Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)